Capital Bank & Trust’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-25,631
Closed -$2.54M 894
2019
Q3
$2.54M Buy
25,631
+25,391
+10,580% +$2.41M 0.04% 159
2019
Q2
$22K Hold
240
﹤0.01% 493
2019
Q1
$23K Sell
240
-70
-23% -$6.12K ﹤0.01% 460
2018
Q4
$20K Sell
310
-446
-59% -$32.9K ﹤0.01% 508
2018
Q3
$68K Buy
756
+96
+15% +$8.48K ﹤0.01% 412
2018
Q2
$52K Sell
660
-50
-7% -$4.15K ﹤0.01% 415
2018
Q1
$63K Sell
710
-11
-2% -$1.06K ﹤0.01% 362
2017
Q4
$75K Sell
721
-106
-13% -$12K ﹤0.01% 384
2017
Q3
$121K Buy
827
+517
+167% +$70.4K ﹤0.01% 309
2017
Q2
$40K Buy
+310
New +$38K ﹤0.01% 373

Other funds holding CELG

Capital Bank & Trust's CELG Position: Q4 2019 in Review

Capital Bank & Trust sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 25,631 shares — an estimated $2.54M sold.

Capital Bank & Trust first reported a position in CELG in Q2 2017 and held it in 10 quarters. The position peaked at $2.54M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Capital Bank & Trust reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Capital Bank & Trust sold 25,631 Celgene Corp shares in Q4 2019, an estimated $2.54M.
  • Capital Bank & Trust first reported a position in Celgene Corp in Q2 2017 and held it in 10 quarters.
  • Capital Bank & Trust's Celgene Corp position peaked at $2.54M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Capital Bank & Trust's 13F filing for Q4 2019, filed 18 Feb 2020.